In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse.
A promising therapeutic approach for Duchenne muscular dystrophy (DMD) is exon skipping using antisense oligonucleotides (AOs). In-frame deletions of the hinge 3 region of the dystrophin protein, which is encoded by exons 50 and 51, are predicted to cause a variety of phenotypes. Here, we performed...
主要な著者: | Aoki, Y, Nakamura, A, Yokota, T, Saito, T, Okazawa, H, Nagata, T, Takeda, S |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2010
|
類似資料
-
Bodywide skipping of exons 45-55 in dystrophic mdx52 mice by systemic antisense delivery.
著者:: Aoki, Y, 等
出版事項: (2012) -
Hexose enhances oligonucleotide delivery and exon skipping in dystrophin-deficient mdx mice
著者:: Gang Han, 等
出版事項: (2016-03-01) -
Use of antisense-mediated exon skipping to generate dystrophin in muscles of the mdx dystrophic mouse
著者:: Lu, Q, 等
出版事項: (2004) -
Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse.
著者:: Lu, Q, 等
出版事項: (2003) -
A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice.
著者:: Yin, H, 等
出版事項: (2009)